| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |